A Single-arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates
Conditions
Hypercalcemia
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Amgen, Inc
- Dates:
- February 2010
- Last Updated:
- Study HIC#:
- 0908005536
Clinicaltrials.gov ID: Yale2544018
For more information about this trial, contact:
Investigator
Karl Insogna, MD
Principal Investigator
